Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ainos Regains Nasdaq Compliance, Accelerates AI Nose Platform Commercialization With 90-Day Execution Plan

Author: Benzinga Newsdesk | July 16, 2025 08:09am

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The compliance confirmation comes as Ainos gains momentum across its AI Nose platform, with strategic deployments, commercial partnerships, and a 90-day execution plan aimed at enabling large-scale commercialization by 2026.

Recent AI Nose Milestones Driving Growth

Strategic partnership with ASE Technology Holding (ASEH), the world's largest semiconductor packaging and testing company, with a targeted phased deployment plan of up to 15,000 AI Nose units.

Expanded industrial footprint through partnerships with Kenmec and Solomon, aiming to integrate AI-powered scent intelligence powered by AI Nose and smell language model (SLM) into smart factory and machine vision ecosystems across Asia.

Completed the world's first integration of AI Nose with a humanoid robot, for embedding digital olfactory sensing capabilities into ugo Inc.'s service robotics platform.

Smell language model (SLM) surpassed 90% accuracy in classifying everyday scents, including meat, food, and beverages.

Senior care program improved accuracy to ~85% from ~80%.

412% year-over-year revenue increase in Q1 2025, driven by initial AI Nose sales for the senior care program.

Key Strategic Priorities for the Next 90 Days

Building toward its 2026 scale-up, Ainos will focus on the following near-term priorities:

Complete pilot deployment of approximately 1,400 AI Nose units with ASEH and initiate Phase 1 expansion to approximately 5,000 units.

With Kenmec, exhibit the AI Nose integrated ugo robot at Automation Taipei, to be held August 20-23 in Taiwan.

Drive SmellTech-as-a-Service (SaaS) as a subscription-based revenue model for AI Nose deployments and Smell ID services.

Enhance SLM performance through broad-scale validation and expanded real-world testing.

Pursue additional strategic partnerships in Asia and Europe for technology licensing and regional commercialization.

On July 15, 2025, the Company received formal notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") confirming that Ainos' common stock maintained a closing bid price of $1.00 or higher for ten consecutive business days, from June 30, 2025 to July 14, 2025. According to the Notice, the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and this matter is now officially closed.

Posted In: AIMD AIMDW

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist